• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance
    Get the next $AZN alert in real time by email

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month.

    Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq-100 Sustainable ESG Select™​ (NDXSES™), Nasdaq-100 Low Volatility​™ (NDXLV™), and Nasdaq-100 Select Equal Weight™​ (NDXSE™) prior to market open on Tuesday, January 20, 2026. Please also note that the market will be closed on Monday, January 19, 2026, in observance of MLK, Jr. Day.

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy.

    To learn more about the Nasdaq-100 Index methodology, visit: https://indexes.nasdaq.com/docs/Methodology_NDX.pdf

    For more information about the company, go to https://stock.walmart.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been a leader in transparent, market-driven index solutions since 1971. We offer a comprehensive range of indexes spanning asset classes, sectors, and geographies, delivering benchmarks that reflect today's dynamic markets. Our mission is to create innovative opportunities for financial product sponsors and asset managers to measure risk and performance, supported by personalized index design and solutions tailored to the evolving needs of investors worldwide. To learn more about Nasdaq Global Indexes, visit: https://www.nasdaq.com/solutions/global-indexes

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.



    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger Name: Index Client Services
    Email: [email protected] Email: [email protected]
       
       

    -NDAQF-



    Primary Logo

    Get the next $AZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZN
    $NDAQ
    $WMT

    CompanyDatePrice TargetRatingAnalyst
    Walmart Inc.
    $WMT
    2/20/2026$131.00Buy → Hold
    HSBC Securities
    Walmart Inc.
    $WMT
    2/20/2026$135.00 → $140.00Outperform
    Telsey Advisory Group
    AstraZeneca PLC
    $AZN
    1/27/2026Buy
    Citigroup
    Walmart Inc.
    $WMT
    1/8/2026$119.00Buy → Hold
    Deutsche Bank
    Walmart Inc.
    $WMT
    11/21/2025$118.00 → $130.00Outperform
    Telsey Advisory Group
    Nasdaq Inc.
    $NDAQ
    11/20/2025$110.00Equal-Weight → Overweight
    Morgan Stanley
    AstraZeneca PLC
    $AZN
    10/27/2025Buy
    Jefferies
    AstraZeneca PLC
    $AZN
    10/16/2025Hold → Sell
    Deutsche Bank
    More analyst ratings

    $AZN
    $NDAQ
    $WMT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Walmart downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Walmart from Buy to Hold and set a new price target of $131.00

    2/20/26 8:23:03 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Walmart with a new price target

    Telsey Advisory Group reiterated coverage of Walmart with a rating of Outperform and set a new price target of $140.00 from $135.00 previously

    2/20/26 7:54:52 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Citigroup initiated coverage on AstraZeneca

    Citigroup initiated coverage of AstraZeneca with a rating of Buy

    1/27/26 8:43:14 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZN
    $NDAQ
    $WMT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Director Moritz Robert Edward Jr. bought $499,997 worth of Common (5,446 units at $91.81), increasing direct ownership by 231% to 7,805 units (SEC Form 4)

    4 - Walmart Inc. (0000104169) (Issuer)

    11/29/24 5:12:06 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AZN
    $NDAQ
    $WMT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Vice President Bartlett Daniel J sold $167,179 worth of Common (1,255 units at $133.21), decreasing direct ownership by 0.21% to 586,329 units (SEC Form 4)

    4 - Walmart Inc. (0000104169) (Issuer)

    2/19/26 6:40:27 PM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Chair and CEO Friedman Adena T was granted 270,195 shares and covered exercise/tax liability with 115,775 shares, increasing direct ownership by 8% to 2,079,323 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/17/26 4:03:12 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AZN
    $NDAQ
    $WMT
    SEC Filings

    View All

    SEC Form 6-K filed by AstraZeneca PLC

    6-K - ASTRAZENECA PLC (0000901832) (Filer)

    2/20/26 6:57:38 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Walmart Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Walmart Inc. (0000104169) (Filer)

    2/19/26 6:59:55 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 10-K filed by Nasdaq Inc.

    10-K - NASDAQ, INC. (0001120193) (Filer)

    2/12/26 4:29:07 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AZN
    $NDAQ
    $WMT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting

    CALQUENCE plus venetoclax demonstrated statistically significant and clinically meaningful improvement in progression-free survival vs. chemoimmunotherapy, with 77% of patients progression free at three years in AMPLIFY Phase III trial AstraZeneca's CALQUENCE® (acalabrutinib) in combination with venetoclax has been approved in the US as the first all-oral, fixed-duration regimen for the treatment of adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). The approval by the US Food and Drug Administration (FDA) was based on positive results from the AMPLIFY Phase III trial, which were presented at the American Society of Hematology 2024 Annual Meetin

    2/20/26 7:00:00 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Walmart Raises Annual Dividend to $0.99 per Share, Marking 53rd Consecutive Year of Dividend Increases

    The Board of Directors of Walmart Inc. (NASDAQ:WMT) approved an annual cash dividend for fiscal year 2027 of $0.99 per share. This represents a 5 percent increase from the $0.94 per share paid for the last fiscal year. The fiscal year 2027 annual dividend of $0.99 per share will be paid in four quarterly installments of $0.2475 per share, according to the following record and payable dates: Record Dates Payable Dates March 20, 2026 April 6, 2026 May 8, 2026 May 26, 2026 Aug. 21, 2026 Sept. 8, 2026 Dec. 11, 2026 Jan. 4, 2027 "Dividends continue to be a part of our diversified capital returns approach. We're proud to be

    2/19/26 7:03:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Walmart reports revenue growth of 5.6%, up 4.9% in constant currency (cc)

    Operating income growing faster at 10.8%, up 10.5% adjusted (cc) eCommerce sales up 24% globally GAAP EPS of $0.53; Adjusted EPS of $0.74 Company announces new $30 billion share repurchase authorization Company provides outlook for Q1 and FY27 Walmart Inc. (NASDAQ:WMT): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218203787/en/ Fourth Quarter Highlights: Revenue of $190.7 billion, up 5.6%, or 4.9% (cc) Global eCommerce sales grew 24%, led by store-fulfilled pickup & delivery and marketplace Global advertising business up 37%, including VIZIO; Walmart Connect in the U.S. up 41% Membership fee revenue gr

    2/19/26 7:02:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AZN
    $NDAQ
    $WMT
    Financials

    Live finance-specific insights

    View All

    Walmart Raises Annual Dividend to $0.99 per Share, Marking 53rd Consecutive Year of Dividend Increases

    The Board of Directors of Walmart Inc. (NASDAQ:WMT) approved an annual cash dividend for fiscal year 2027 of $0.99 per share. This represents a 5 percent increase from the $0.94 per share paid for the last fiscal year. The fiscal year 2027 annual dividend of $0.99 per share will be paid in four quarterly installments of $0.2475 per share, according to the following record and payable dates: Record Dates Payable Dates March 20, 2026 April 6, 2026 May 8, 2026 May 26, 2026 Aug. 21, 2026 Sept. 8, 2026 Dec. 11, 2026 Jan. 4, 2027 "Dividends continue to be a part of our diversified capital returns approach. We're proud to be

    2/19/26 7:03:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Walmart reports revenue growth of 5.6%, up 4.9% in constant currency (cc)

    Operating income growing faster at 10.8%, up 10.5% adjusted (cc) eCommerce sales up 24% globally GAAP EPS of $0.53; Adjusted EPS of $0.74 Company announces new $30 billion share repurchase authorization Company provides outlook for Q1 and FY27 Walmart Inc. (NASDAQ:WMT): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260218203787/en/ Fourth Quarter Highlights: Revenue of $190.7 billion, up 5.6%, or 4.9% (cc) Global eCommerce sales grew 24%, led by store-fulfilled pickup & delivery and marketplace Global advertising business up 37%, including VIZIO; Walmart Connect in the U.S. up 41% Membership fee revenue gr

    2/19/26 7:02:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Walmart To Host Fourth Quarter Earnings Conference Call February 19, 2026

    Walmart Inc. (NASDAQ:WMT) announced it will release its fourth quarter earnings results at 6 a.m. CST and hold a live conference call with the investment community at 7 a.m. CST on Thursday, February 19, 2026. John Furner, president and chief executive officer, and John David Rainey, executive vice president and chief financial officer, will host the call to discuss the results and answer questions. Links to access earnings information: Earnings Materials Live Webcast Webcast Archive About Walmart Walmart Inc. (NASDAQ:WMT) is a people-led, tech-powered omnichannel retailer helping people save money and live better - anytime and anywhere - in stores, online, and through their

    2/12/26 6:00:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AZN
    $NDAQ
    $WMT
    Leadership Updates

    Live Leadership Updates

    View All

    Walmart Inc. to Join the Nasdaq-100 Index® Beginning January 20th, 2026

    NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Walmart Inc. (NASDAQ:WMT), will become a component of the Nasdaq-100 Index® (NDX®), the Nasdaq-100 Equal Weighted™ Index (NDXE™), and the Nasdaq-100 Ex-Tech Sector™ Index (NDXX™) prior to market open on Tuesday, January 20, 2026 - the first trading day following the third Friday of the month. Walmart Inc. will replace AstraZeneca PLC (NASDAQ:AZN) in the Nasdaq-100 Index®, the Nasdaq-100 Equal Weighted Index, and the Nasdaq-100 Ex-Tech Sector Index. AstraZeneca PLC will also be removed from the Nasdaq-100 ESG™ Index (NDXESG™), Nasdaq-100 ex Top 30™​ (NDX70™), Nasdaq-100 ex Top 30​ UCITS™ (NDX70U™), Nasdaq

    1/9/26 8:00:00 PM ET
    $AZN
    $NDAQ
    $WMT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Walmart names Shishir Mehrotra to Board of Directors

    Walmart Inc. (NASDAQ:WMT) announced the appointment of Shishir Mehrotra, Chief Executive Officer at Superhuman (formerly Grammarly), to the company's Board of Directors, effective today. He will serve on the Board's Compensation and Management Development Committee and the Technology and eCommerce Committee. "Our focus remains on serving customers through a people-led, tech-powered approach," said Greg Penner, chairman of Walmart's Board of Directors. "Shishir's background adds to our boardroom the insight of a proven builder, offering a distinguished track record scaling platforms relied upon by millions." Randall Stephenson, lead independent director, added: "Shishir brings a rare com

    1/8/26 8:02:00 AM ET
    $WMT
    Department/Specialty Retail Stores
    Consumer Discretionary

    Nasdaq Maintains Over a Decade of Listings Leadership in 2025

    Largest Exchange Transfer in History & Biggest IPO of the Year Highest Capital Raised Since 2021 - $46.65 Billion Raised NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In addition, 22 companies transferred their corporate listings to Nasdaq in 2025 including Walmart, the largest exchange transfer in history. Since 2005, companies transferring their listing to Nasdaq have represented more than $4 trillion in total market value. "2025 marked a meaningful resurgence for the public markets. Companies at every stage continue to choose

    12/18/25 7:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $AZN
    $NDAQ
    $WMT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

    SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

    11/12/24 3:53:01 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Nasdaq Inc.

    SC 13G - NASDAQ, INC. (0001120193) (Subject)

    11/8/24 10:52:39 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

    SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

    11/4/24 1:18:47 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance